Search Results - "Tomaras, Georgia"

Refine Results
  1. 1

    Complex immune correlates of protection in HIV‐1 vaccine efficacy trials by Tomaras, Georgia D., Plotkin, Stanley A.

    Published in Immunological reviews (01-01-2017)
    “…Summary Development of an efficacious HIV‐1 vaccine is a major priority for improving human health worldwide. Vaccine‐mediated protection against human…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies by Chu, Thach H, Crowley, Andrew R, Backes, Iara, Chang, Cheryl, Tay, Matthew, Broge, Thomas, Tuyishime, Marina, Ferrari, Guido, Seaman, Michael S, Richardson, Simone I, Tomaras, Georgia D, Alter, Galit, Leib, David, Ackerman, Margaret E

    Published in PLoS pathogens (24-02-2020)
    “…Antibody functions such as neutralization require recognition of antigen by the Fab region, while effector functions are additionally mediated by interactions…”
    Get full text
    Journal Article
  4. 4

    The immune response during acute HIV-1 infection: clues for vaccine development by McMichael, Andrew J, Borrow, Persephone, Tomaras, Georgia D, Goonetilleke, Nilu, Haynes, Barton F

    Published in Nature reviews. Immunology (01-01-2010)
    “…Key Points The early virological factors in HIV-1 infection, including transmission and the nature of the founder virus, can affect the time course of viraemia…”
    Get full text
    Journal Article
  5. 5

    Bringing the path toward an HIV-1 vaccine into focus by Lopez Angel, Cesar J, Tomaras, Georgia D

    Published in PLoS pathogens (10-09-2020)
    “…About the Authors: Cesar J. Lopez Angel Affiliations Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California,…”
    Get full text
    Journal Article
  6. 6

    Immune correlates of vaccine protection against HIV-1 acquisition by Corey, Lawrence, Gilbert, Peter B, Tomaras, Georgia D, Haynes, Barton F, Pantaleo, Giuseppe, Fauci, Anthony S

    Published in Science translational medicine (21-10-2015)
    “…The partial efficacy reported in the RV144 HIV vaccine trial in 2009 has driven the HIV vaccine field to define correlates of risk associated with HIV-1…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination by Cram, Jacob A, Fiore-Gartland, Andrew J, Srinivasan, Sujatha, Karuna, Shelly, Pantaleo, Giuseppe, Tomaras, Georgia D, Fredricks, David N, Kublin, James G

    Published in PloS one (23-12-2019)
    “…Antibodies that recognize commensal microbial antigens may be cross reactive with a part of the human immunodeficiency virus (HIV) envelope glycoprotein gp41…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Parameter estimation and identifiability analysis for a bivalent analyte model of monoclonal antibody-antigen binding by Nguyen, Kyle, Li, Kan, Flores, Kevin, Tomaras, Georgia D., Dennison, S. Moses, McCarthy, Janice M.

    Published in Analytical biochemistry (15-10-2023)
    “…Surface plasmon resonance (SPR) is an extensively used technique to characterize antigen-antibody interactions. Affinity measurements by SPR typically involve…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Vaccination establishes clonal relatives of germinal center T cells in the blood of humans by Heit, Antje, Schmitz, Frank, Gerdts, Sarah, Flach, Britta, Moore, Miranda S, Perkins, Jonathan A, Robins, Harlan S, Aderem, Alan, Spearman, Paul, Tomaras, Georgia D, De Rosa, Stephen C, McElrath, M Juliana

    Published in The Journal of experimental medicine (03-07-2017)
    “…Germinal center T follicular helper cells (GCTfh) in lymphatic tissue are critical for B cell differentiation and protective antibody induction, but whether…”
    Get full text
    Journal Article
  19. 19
  20. 20